Genomic Vision Email Format
Biotechnology ResearchÎle-de-france, France11-50 Employees
Genomic Vision is a biotechnology research company focused on diagnostic and drug-discovery solutions built around nanotechnology-enabled DNA analysis, with an emphasis on cancer and acute diseases. It employs a method that enables direct visualization of individual DNA molecules to detect both quantitative and qualitative changes in the genome and to assess how these changes relate to pathology. Headquartered in Bagneux, Île-de-France, France, the company serves researchers and clinicians seeking early cancer detection and therapy monitoring, offering tests and tools to identify genomic biomarkers and to study DNA replication during cell division. This positioning places Genomic Vision in the specialized segment of genome analysis within biotechnology research, supporting work on drug efficacy and patient care. In 2023 the company launched FiberSmart, an AI-based software designed to automate the quantification and detection of fluorescent signals on combed DNA, reflecting its ongoing integration of software with its genomic analysis capabilities.